Article
Migraine polygenic risk score associates with efficacy of migraine-specific drugs
24 Oct 2019
Abstract excerpt
OBJECTIVE: To assess whether the polygenic risk score (PRS) for migraine is associated with acute and/or prophylactic migraine treatment response. METHODS: We interviewed 2,219 unrelated patients at the Danish Headache Center using a semistructured interview to diagnose migraine and assess acute and prophylactic drug response. All patients were genotyped. A PRS was calculated with the linkage disequilibrium pred...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
